The compounds and methods of the present disclosure exhibit induce Ucp1 transcription, enhance of
mitochondrial respiration, activate
protein kinase A, increase
lipolysis, and increase p38 MAPK
phosphorylation in cells, particularly
brown adipocytes and white adipocytes. They also protect primary cardiomyocytes against hypertrophy induced by
adrenergic agonists. Such compounds and methods are useful in the treatment and prevention of conditions such as
obesity and associated complex metabolic, endocrine, and hemodynamic changes, as well as related conditions as dyslipidemias, cardiovascular
disease, and type 2 diabetes.